Psoriasis Drug May Help Preserve Pancreas Cells in Type 1 Diabetes
Psoriasis Drug May Help Preserve Pancreas Cells in Type 1 Diabetes
Used early after diagnosis, drug appears to have long-lasting effects, study reports
"Achieving long-term benefit following a short course of therapy is a challenging goal," Dr. Gerald Nepom, director of the Immune Tolerance Network, said in the news release.
"Detailed analysis of the T-cell types present in the blood of those who responded to the treatment will help us identify the best way to improve this type of immune therapy for patients with type 1 diabetes and potentially other autoimmune diseases," he added.
The study results were published July 20 in the Journal of Clinical Investigation.
Drug May Help Pancreas Cells in Type 1 Diabetes
Used early after diagnosis, drug appears to have long-lasting effects, study reports
"Achieving long-term benefit following a short course of therapy is a challenging goal," Dr. Gerald Nepom, director of the Immune Tolerance Network, said in the news release.
"Detailed analysis of the T-cell types present in the blood of those who responded to the treatment will help us identify the best way to improve this type of immune therapy for patients with type 1 diabetes and potentially other autoimmune diseases," he added.
The study results were published July 20 in the Journal of Clinical Investigation.